Should each 25 g (100 mL) ampoule of 25 % albumin be infused over one hour?

Albumin Infusion Rate: One Hour Per 100 mL Vial is NOT Standard Practice

For 25% albumin (25 g/100 mL), there is no universal requirement to infuse each vial over exactly one hour. The appropriate infusion rate depends entirely on the clinical indication and patient hemodynamic status, with rates varying from as rapid as possible in shock states to slower infusions (not exceeding 2 mL/min) in hypoalbuminemic patients at risk for circulatory overload.

Clinical Context Determines Infusion Rate

The FDA label for 25% albumin provides critical guidance: in hypoproteinemic patients with approximately normal blood volumes, the rate should not exceed 2 mL per minute to prevent circulatory embarrassment and pulmonary edema 1. This translates to a minimum infusion time of 50 minutes for a 100 mL vial—close to your proposed one hour, but this applies ONLY to specific clinical scenarios.

Rapid Infusion Scenarios

In hypovolemic shock, the FDA label explicitly states that "the volume administered and the speed of infusion should be adapted to the response of the individual patient" 1. For anaphylaxis with refractory hypotension, guidelines recommend rapid administration of 500 mL colloid solution followed by slow infusion 2. In septic shock requiring large volume resuscitation, albumin is typically given more rapidly as part of aggressive fluid management 3.

Slower Infusion Requirements

Hypoalbuminemic patients with normal or expanded blood volumes require slower rates. The 2 mL/min maximum (approximately 1 hour per 100 mL) prevents:

• Circulatory overload
• Pulmonary edema
• Acute decompensation in patients with limited cardiac reserve

Research demonstrates that infusion rate significantly impacts efficacy and safety. A 2023 study found that standard-dose albumin (1.5 g/kg) infused over 6 hours caused symptomatic circulatory overload in 100% of patients, requiring premature discontinuation 4. This highlights that even "standard" infusion times may be too rapid for certain populations.

Specific Clinical Indications and Rates

Hepatorenal Syndrome

For hepatorenal syndrome, guidelines recommend 1 g/kg/day up to 100 g/day for at least 2 days 5. This typically involves infusing 100 mL vials over 1-2 hours, but the total daily dose matters more than individual vial infusion time 6.

Spontaneous Bacterial Peritonitis

1.5 g/kg within 6 hours of diagnosis, followed by 1 g/kg on day 3 7. The initial dose for a 70 kg patient (105 g = approximately 4 vials of 100 mL) should be given over several hours, not as four separate 1-hour infusions 7.

Large Volume Paracentesis

8 g albumin per liter of ascites removed, infused after paracentesis completion 7. For removal of >5 L, this means 40+ grams, typically given over 2-4 hours post-procedure.

Evidence on Continuous vs. Bolus Administration

Continuous infusion may be superior to bolus dosing in certain populations. A 1996 pediatric study demonstrated that continuous 24-hour albumin infusion resulted in steadier increases in blood albumin concentration (34% increase at 24 hours) compared to 4-hour boluses (14% increase), with calculated half-life of only 4.6 hours for bolus administration 8. However, a 2024 study in surgical-trauma patients with open abdomen found that continuous albumin infusion was associated with longer time to abdomen closure compared to crystalloids 9.

Common Pitfalls to Avoid

1. Do not use a fixed "one hour per vial" rule across all indications—this oversimplifies complex hemodynamic management
2. Monitor for circulatory overload during infusion, particularly in patients with:
   • Baseline hypoalbuminemia with normal blood volume
   • Heart failure or renal disease
   • Elderly patients
3. Avoid albumin in traumatic brain injury—associated with harm 5
4. Do not use albumin for nutritional purposes or simple hypoalbuminemia without specific indications 5, 10

Practical Approach

For your 50 gram order (2 × 100 mL vials of 25% albumin):

• If patient has hypovolemic/septic shock: Infuse as rapidly as tolerated based on hemodynamic response, potentially 30-60 minutes per vial
• If patient has hypoalbuminemia with normal blood volume: Infuse at ≤2 mL/min (minimum 50 minutes per vial, up to 2 hours acceptable)
• If patient has liver disease with ascites/SBP: Infuse over 2-6 hours total for the complete dose based on indication
• If patient has heart failure or renal disease: Consider slower rates (2-4 hours per vial) with careful monitoring

The safest default approach when indication is unclear: infuse each 100 mL vial over 1-2 hours while monitoring for signs of volume overload (respiratory distress, elevated jugular venous pressure, new pulmonary crackles). This balances efficacy with safety across most clinical scenarios.